Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn which cryptocurrencies are expected to perform best in 2023, allowing you to invest smartly for optimal returns. Start exploring!
21,669 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Market pullbacks happen. Some assets recover faster than others. This article explains why a Vanguard ETF with a shor...
When a senior leader at Black Stone Minerals sells a sizeable block of units, it can ripple through the stock. This a...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
A private Philadelphia moment between Beyoncé and Jay-Z offers more than star power. This piece breaks down the finan...
A sharp 20% drop has traders buzzing about Silicon Motion Technology. This guide breaks down the opportunity, the ris...
Rising mortgage rates change buyer behavior and put pressure on single-family demand. This guide explains how mortgag...
Pi Network confirms the long-anticipated network update finally, announcing a successful v19.6 migration and outlinin...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...
What could drive Entravision's 2025 earnings, and what should investors watch next? This guide breaks down the driver...
As automation accelerates, ex-presidential candidate Andrew Yang revives a bold tax idea: shift the burden from labor...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...